Review article: The dietary management of Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 1, 1997, Pages 17-31

  King, T S ^a   Woolner, J T ^a   Hunter, J O ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALAZOSULFAPYRIDINE;

CROHN DISEASE; DIET; ENTERIC FEEDING; HUMAN; NUTRIENT; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; REVIEW;

EID: 0031015065     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.90262000.x     Document Type: Review

References (120)

1. Podolsky DK. Inflammatory bowel disease. (First of two parts.) N Engl J Med 1991; 13: 928-37.
2. Haens GRD, Gasparaitis AE, Hanauer SB. Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gut 1995; 36: 715-7.
3. Greenstein JP, Otey MC, Birnbaum SM, Winitz M. Quantitative nutritional studies with water-soluble, chemically defined diets (x) formulation of a nutritionally complete liquid diet. J Natl Cancer Inst 1960; 24: 211.
4. Couch RB, Watkin DM, Smith RR, et al. Clinical trials of water soluble chemically defined diets. Fed Proc 1960; 19: 13.
5. Winitz M, Seedman DA, Graff J. Studies in metabolic nutrition employing chemically defined diets. 1. Extended feeding of normal human adult males. Am J Clin Nutr 1970; 23: 525-45.
6. Voitk AJ, Echave V, Feller JH, Brown RA, Gurd FN. Experience with elemental diet in the treatment of inflammatory bowel disease: is this primary therapy? Arch Surg 1973; 107: 329-33.
7. Rocchio MA, Cha CM, Haas KF, Randall HT. Use of chemically defined diets in the management of patients with acute inflammatory bowel disease. Am J Surg 1974; 127: 469-75.
8. O'Morain, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J 1984; 288: 1859-62.
9. Seidman EG, Lohoues MJ, Turgeon J, Bouthillier L, Morin CL. Elemental diet versus prednisolone as initial therapy in Crohn's disease: early and long term results. Gastroenterology 1991; 100: A250(Abstract).
10. Hunt JB, Payne-James JJ, Palmer KR, et al. A randomised controlled trial of elemental diet and prednisolone as primary therapy in acute exacerbations of Crohn's disease. Gastroenterology 1989; 96: A224(Abstract).
11. Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993; 34: 1198-1202.
12. Malchow H, Steinhardt HJ, Lorenz-Meyer H, et al. Feasibility and effectiveness of a defined formula diet regimen in treating active Crohn's disease; European Co-operative Crohn's disease study III. Scand J Gastroenterol 1990; 25: 235-44.
13. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al. Comparison of enterai nutrition and drug treatment in active Crohn's disease: results of the European Co-operative Crohn's disease study IV. Gastroenterology 1991; 101: 881-8.
14. Seidman E, Griffiths A, Jones A, Issenman R. Semi-elemental diet versus prednisone in paediatric Crohn's disease. Gastroenterology 1992; 104: A778(Abstract).
15. González-Huix F, de León R, Fernández-Bañares F, et al. Polymeric enterai diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993; 34: 778-82.
16. Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet 1990; 335: 816-9.
17. Raouf AH, Hildrey V, Daniel J, et al. Enterai feeding as sole treatment for Crohn's disease: controlled trial of whole protein versus amino acid based feed and a case study of dietary challenge. Gut 1991; 32: 702-7.
18. Rigaud D, Cosnes J, Le Quintrec Y, et al. Controlled trial comparing two types of enterai nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut 1991; 32: 1492-7.
19. Royall d, Jeejeebhoy KN, Baker JP, et al. Comparison of amino acid versus peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 1994; 35: 783-7.
20. Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut 1995; 36: 60-6.
21. Middleton SJ, Riordan AM, Hunter JO. Comparison of elemental and peptide based diets in treatment of acute Crohn's disease, Ital J Gastroenterol 1991; 23: 609.
22. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR, Metaanalysis of enterai nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108: 1056-67.
23. Summers RW, Switz DM, Sessions JT, et al. National co-operative Crohn's disease study: results of drug treatment. Gastroenterology 1979; 77: 847-69.
24. Malchow H, Ewe K, Brandes JW, et al. European co-operative Crohn's disease study: results of drug treatment. Gastroenterology 1984; 86: 249-66.
25. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index: national co-operative Crohn's disease study. Gastroenterology 1976; 70: 439-44.
26. De Dombal FT, Softley A. IOIBD report no. 1: observer variation in calculating indices of severity and activity in Crohn's disease. Gut 1987; 28: 474-81.
27. Teahon K, Smethurst P, Pearson M, Levi AJ, Bjarnason I. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology 1991; 101: 84-9.
28. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995; 14: 229-36.
29. Greenberg GR, Fleming CR, Jeejeebhoy KN, et al. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988; 29: 1309-15.
30. Lochs H, Meryn S, Marosi L, Ferenci P, Hörtnagl H. Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr 1983; 2: 61-4.
31. Levine GM, Deren JJ, Steiger E, Zinno R. Role of oral intake in maintenance of gut mass and disaccharide activity. Gastroenterology 1974; 67: 975-82.
32. Zoli G, Carè M, Falco F, et al. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease. Gut 1995; 37 (Suppl. 2): A13(Abstract).
33. Murphy JL, Wootton SA, Rucker JT, Kirby GA, Hunter JO. The effect of an elemental diet on stool output in Irritable Bowel Syndrome. Proc Nutr Soc 1994; 53: 223A(Abstract).
34. Videla S, Vilaseca J, Guarner F, et al. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 1994; 35: 1090-7.
35. Kane SP, Neale G, Ileocolitis responding to bowel sterilisation. Proc R Soc Med 1976; 69: 266.
36. Winitz M, Adams RF, Seedman DA, et al. Studies in metabolic nutrition employing chemically defined diets: II Effects on gut microflora populations. Am J Clin Nutr 1970; 23: 546-59.
37. Attebury HR, Sutter VL, Finegold SM. Effect of a partially chemically defined diet on normal human gut flora. Am J Clin Nutr 1972; 25: 1391-8.
38. Bounous G, Devroede GJ. Effects of an elemental diet on human fecal flora. Gastroenterology 1974; 66: 210-4.
39. Axelsson CK, Justessen T. Studies of the duodenal and faecal flora in gastrointestinal disorders during treatment with an elemental diet. Gastroenterology 1977; 72: 397-401.
40. O'Morain CA. Does nutritional therapy in inflammatory bowel disease have a primary or an adjunctive role? Scand J Gastroenterol 1990; 25 (S172): 29-34.
41. Gassull MA, Fernández-Bañares F, Esteve-Comas M. Nutrition in inflammatory bowel disease. In: Payne-James JJ, Grimble G, Silk D, eds. Artificial Nutrition Support in Clinical Practice. London: Edward Arnold, 1995.
42. McArdle AH, Echave W, Brown RA, Thompson AG. Effect of elemental diet on pancreatic secretion. Am J Surg 1974; 179: 226-9.
43. Hill GL, Mair WSJ, Edwards JP, Goligher JC. Decreased trypsin and bile acids in ileal fistula drainage during the administration of a chemically defined liquid elemental diet. Br J Surg 1976; 63: 133-6.
44. Go VLW, Hoffmann AF, Summerskill WHJ. Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive products. J Clin Invest 1970; 49: 1558-64.
45. Teahon K, Bjarnason I, Pearson M, Levi AJ. Ten years' experience with an elemental diet in the management of Crohn's disease. Gut 1990: 31: 1133-7.
46. Nelson LM, Carmichael HA, Russell RI, Atherton ST. Use of an elemental diet (Vivonex) in the management of bile acid induced diarrhoea. Gut 1977; 18: 792-4.
47. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhoea associated with ileal resection. N Engl J Med 1969; 281: 397-402.
48. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhoea associated with ileal resection: factors influencing response. Gastroenterology 1969; 56: 1168 (Abstract).
49. Bury KD, Stephens RV, Randall HT. Use of a chemically defined, liquid, elemental diet for nutritional management of fistulas of the alimentary tract. Am J Surg 1971; 121: 174-81.
50. Axelsson C, Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol 1977; 12: 89-95.
51. Calam J, Crooks PE, Walker RJ. Elemental diets in the management of Crohn's perianal fistulae. J Parent Ent Nutr 1980; 4: 4-8.
52. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; i: 514.
53. Schofield WN, Schofield C, James WPT. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr: Clin Nutr 1985; 39C (Suppl. 1): 5-96.
54. Elia M. Artificial nutritional support. Med Int 1990; 82: 3392-6.
55. Keohane PP, Silk DBA. Peptides and free amino acids. In: Rombeau JL, Caldwell MD, eds. Enterai and Tube Feeding, 1st edn. London: Saunders, 1984: 44-59.
56. Pearson M, Teahon K, Levi AJ, Bjarnason I. Food intolerance and Crohn's disease. Gut 1993; 34: 783-7.
57. Middleton SJ, Hunter JO. Therapeutic aspects of nutrition in Crohn's disease. J Irish Coll Physicians Surg 1995; 24: 36-9.
58. Teahon K, Pearson M, Levi AJ, Bjarnason I. Practical aspects of elemental diet in the management of patients with Crohn's disease. Gastroenterology 1991; 100: A256 (Abstract).
59. Collins EM, Pritchett CP. Allergy as a factor in disturbances of the gastrointestinal tract. Med Clin North Am 1938; 22: 297-317.
60. Rowe AH, Rowe AR, Uyeyama K. Regional enteritis - its allergic aspects. Gastroenterology 1953; 23: 554-71.
61. Alun Jones V, Hunter JO. Irritable bowel syndrome and Crohn's disease. In: Brostoff J, Challacombe SJ, eds. Food Allergy and Intolerance. London: Baillière Tindall, 1987.
62. Ginsberg AL, Albert M. Treatment of patient with severe steroid-dependent Crohn's disease with nonelemental formula diet - identification of possible etiologic dietary factor. Dig Dis Sci 1989; 34: 1624-8.
63. Riordan AM, Rucker JT, Kirby GA, Hunter JO. Food intolerance and Crohn's disease. Gut 1994; 35: 571-2. (Letter.)
64. Workman EM, Alun Jones V, Wilson AJ, Hunter JO. Diet in the management of Crohn's disease. Hum Nutr: Appl Nutr 1984; 38A: 469-73.
65. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J 1979; 2: 764-6.
66. Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br Med J 1987; 295: 517-21.
67. Alun Jones V, Workman E, Freeman AH, et al. Crohn's disease: maintenance of remission by diet. Lancet 1985; ii: 177-80.
68. Giaffer MH, Cann P, Holdsworth CD. Long term effects of elemental and exclusion diets for Crohn's disease. Aliment Pharmacol Ther 1991; 5: 115-25.
69. Riordan AM, Hunter JO, Cowan RE, et al. Treatment of active Crohn's disease by exclusion diet: East Anglia multi-centre controlled trial. Lancet 1993; 342: 1131-4.
70. Lutz W. In: Dismantling a Myth - The Role of Fat and Carbohydrate in Our Diet. Selecta-Verlag Dr Ildar Idris GmbH & Co.: Munich, 1986: 147-52.
71. Macpherson A, Khoo UY, Forgacs I. Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996; 38: 365-75.
72. Gibson GR, Roberfroid MB. Dietary manipulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
73. Hunter JO. Food allergy - or enterometabolic disorder? Lancet 1991; 338.1: 495.
74. Carrette O, Favier C, Mizon C, et al. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease. Dig Dis Sci 1995; 40: 2641-6.
75. Wensinck F, Custers-Van Lieshout MC, Poppelaars-Kustermans PAJ, Schroder AM. The faecal flora of patients with Crohn's disease. J Hyg Camb 1981; 87: 1-12.
76. Hudson MJ, Mill MJ, Elliot PR, et al. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. J Med Microbiol 1984; 18: 335-45.
77. Metcalfe HD, Sampson HA. Workshop on experimental methodology for clinical studies of adverse reactions to foods and food additives. J Allergy Clin Immunol 1990; 86: 421-2.
78. Bock S, Sampson HA, Atkins FM, et al. Double blind, placebo controlled food challenge as an office procedure: a manual. J Allergy Clin Immunol 1988; 82: 986-97.
79. Kelly SM, Riordan A, Hunter JO. Food intolerance in Crohn's disease. In: Anagnostides AA, Hodgson HJF, Kirsner JB, eds. Inflammatory Bowel Disease. London: Chapman and Hall Medical, 1991.
80. Dickinson RJ, Ashton MG, Axon ATR, et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980; 79: 1199-204.
81. Woodbury JF, Kern F Jr. Faecal excretion of bile acids: a new technique for studying bile acid kinetics in patients with ileal resection. J Clin Invest 1971; 50: 2531-40.
82. Gerson CD, Cohen N, Janowitz HD. Small intestinal absorptive function in regional enteritis. Gastroenterology 1973; 64: 907-12.
83. Powell-Tuck J, Garlick PJ, Lennard-Jones JE, Waterlow JC. Rates of whole body protein synthesis and breakdown increase with the severity of inflammatory bowel disease. Gut 1984; 25: 460-4.
84. Beeken WL, Busch HJ, Sylwester DL. Intestinal protein loss in Crohn's disease. Gastroenterology 1972; 62: 207-15.
85. Harries AD, Danis VA, Heatley RV. Influence of nutritional status on immune functions in patients with Crohn's disease. Gut 1984; 25: 465-72.
86. Law DK, Dudrick SJ, Abdou NI. Immunocompetence of patients with protein-calorie malnutrition - the effects of nutritional repletion. Ann Intern Med 1973; 79: 545-50.
87. Lopes J, Russell D McR, Whitwell J, Jeejeebhoy KN. Skeletal muscle function in malnutrition. Am J Clin Nutr 1982; 36: 602-10.
88. Dempsey DT, Mullen JL, Buzby GP. The link between nutritional status and clinical outcome: can nutritional intervention modify it? Am J Clin Nutr 1988; 47: 352-6.
89. Lewis JD, Fisher RL. Nutrition support in inflammatory bowel disease. Med Clin North Am 1994; 78: 1443-56.
90. Royall D, Kahan I, Baker JP, et al. Clinical and nutritional outcome of an elemental versus a semi elemental diet in active Crohn's disease. Gastroenterology 1992; 102: A576(Abstract.)
91. Layden T, Rosenberg J, Nemchausky B, Elson C. Rosenberg I. Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation. Gastroenterology 1976; 70: 1017-21.
92. Morin CL, Roulet M, Roy CC, Weber A. Continuous elemental enteral alimentation in children with Crohn's disease and growth failure. Gastroenterology 1980; 79: 1205-10.
93. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988; 94: 603-10.
94. Silvennoinen JA, Karttunen TJ, Niemala SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37: 71-6.
95. Sambrook P, Birmingham J, Kempler S, et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res 1990; 5: 1211-6.
96. Compston JE. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9: 237-50.
97. Clements D, Compston JE, Evans WD, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993; 34: 1543-6.
98. Hessov I, Hasselblad C, Fasth S, Hulten L. Magnesium deficiency after ileal resections for Crohn's disease. Scand J Gastroenterol 1983; 18: 643-9.
99. Sjögren A, Floren CH, Nilsson Å. Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion. Scand J Gastroenterol 1988; 23: 555-61.
100. Solomons NW, Rosenberg IH, Sandstead HH, Vo-Khactu KP. Zinc deficiency in Crohn's disease. Digestion 1977; 16: 87-95.
101. Main ANH, Hall MJ, Russell RI, et al. Clinical experience of zinc supplementation during intravenous nutrition in Crohn's disease: value of serum and urine zinc measurements. Gut 1982; 23: 984-91.
102. Nakamura T, Higashi A, Takano S, Akagi M, Matsuda I. Zinc clearance correlates with clinical severity of Crohn's disease: a kinetic study. Dig Dis Sci 1988; 33: 1520-4.
103. Hinks LJ, Inwards KD, Lloyd B, Clayton B. Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol 1988; 41: 198-201.
104. Dronfield MW, Malone JDG, Langman MJS. Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels. Gut 1977; 18: 33-6.
105. Wannemacher RW, Pekarek RS, Klainer AS, et al. Detection of leukocytic endogenous mediator-like mediator of serum amino acids and zinc depression during various infectious illnessess. Infect Immun 1975; 11: 873-5.
106. Solomons NW, Elson CO, Pekarek RS, et al. Leukocytic endogenous mediator in Crohn's disease. Infect Immun 1978; 22: 637-9.
107. Fleming CR, Huizenga KA, McCall JT, Gildea J, Dennis R. Zinc nutrition in Crohn's disease. Dig Dis Sci 1981; 26: 865-70.
108. Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989; 84: 744-8.
109. Franklin JL, Rosenberg IH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylsulfapyridine (azulfidine). Gastroenterology 1973; 64: 517-25.
110. Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulphasalazine. J Clin Invest 1978; 61: 221-4.
111. Rosenberg IH, Mason JB. Folate, dysplasia, and cancer. Gastroenterology 1989; 97: 502-5.
112. Russell RM, Smith VC, Multack R, Krill AE, Rosenberg IH. Dark-adaptation testing for diagnosis of sub-clinical vitamin A deficiency and evaluation of therapy. Lancet 1973; ii: 1161-4.
113. Harries AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197-203.
114. Driscoll R, Meredith S, Wagonfeld J, Rosenberg I. Bone histology and vitamin D status in Crohn's disease: assessment of vitamin D therapy. Gastroenterology 1977; 72: 1051 (A28) (Abstract).
115. Compston J, Creamer B. Plasma levels and intestinal absorption of 25-hydroxy vitamin D in patients with small bowel resection. Gut 1977; 18: 171-5.
116. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982; 83: 1252-8.
117. 3 in intestinal disease. Gut 1980; 21: 287-92.
118. 3-evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 1975; 149: 570-2.
119. Lukert BP, Stanbury SW, Maurer EB. Vitamin D and intestinal transport of calcium: effects of prednisolone. Endocrinology 1973; 93: 718-22.
120. 3 and calcium. Gut 1969; 10: 717-22.